Trodelvy® (brand name by Gilead sciences)(sacituzumab govitecan-hziy) is a Trop-2-directed antibody-drug conjugate used to treat metastatic triple-negative and HR+/HER2- breast cancers in adults who have received prior therapies. It delivers SN-38, a topoisomerase-1 inhibitor, to Trop-2-expressing tumor cells, blocking DNA replication and causing cell death.

Mode of action of sacituzumab govitecan-hziy is mainly that it delivers SN-38, a topoisomerase-1 inhibitor, to Trop-2-expressing cancer cells. It treats adults with metastatic triple-negative breast cancer (TNBC) after two or more prior therapies, and HR+/HER2- metastatic breast cancer after endocrine and systemic therapies. It’s also used for locally advanced or metastatic urothelial cancer post-platinum and PD-1/PD-L1 inhibitor treatment. 

Neutropenia, diarrhea, hypersensitivity and infusion-related reactions, nausea and vomiting are the common side effects.  Trodelvy may have teratogenic effects and can cause embryo-fetal lethality when administered during pregnancy. 

Trodelvy promises to help in overall survival of metastatic cancer which is difficult to treat with other therapies, and being a targeted therapy, it allows precise delivery of drugs and an increased chances of survival with less or no progression. 

Pricing and Availability

The price of sacituzumab govitecan-hziy in India may vary depending on market dynamics, supplier availability, and regulatory updates. For the most accurate and updated sacituzumab govitecan-hziy pricing in India, patients can contact us directly.
Pricing may also fluctuate due to GST/local taxes, exchange rates, and changes in company pricing policies.

We help patients buy sacituzumab govitecan in India safely and legally, ensuring full regulatory compliance under the Named Patient Supply (NPS) program and providing assistance throughout the process—from document verification to final delivery.

Access: 

We assist patients and hospitals in legally importing for personal medical use and provide reliable access across major Indian cities. Sacituzumab govitecan-hziy is a prescription drug available as 180 mg lyophilized powder in single-dose vials for reconstitution, for injection. and requires a valid medical prescription from a qualified doctor. It can be imported under the Named Patient Supply (NPS) program, which allows patients to access unapproved or unavailable medicines in India for personal treatment use.

Access Process:

1. Request submission for your medicine: Patients or caregivers can send a request for sacituzumab govitecan-hziy by sharing prescription details and treatment requirements.
2. Submission of an application (Form 12A): Submit an application in Form 12A, along with a valid prescription from a Registered Medical Practitioner (RMP).
3. Verification of documents: We verify the prescription and supporting medical documents to confirm eligibility for importing the drug in small quantities for personal medical use.
4. Permission to import: Once approval is granted by the Drugs Controller General (India), the process of importing medicines begins as per the prescription.
5. Sourcing the medicine: Our sourcing team connects with authorized global suppliers to find the best sacituzumab govitecan-hziy or trodelvy price in India, confirm easy access trodelvy in India, and ensure authenticity before finalizing the offer.
6. Delivery of the medicine: After approval and confirmation, we coordinate logistics and ensure the safe, compliant, and timely delivery of sacituzumab govitecan-hziy to the patient’s location in India.

Documents Require: 

To enable sacituzumab import to India, patients need to provide:

1. A doctor’s prescription specifying the product name, dosage, treatment duration, and diagnosis.
2. Recent medical history and test reports (preferably from the last three months).
3. Government-issued ID proof and proof of residence of the patient.
4. Import permit if applicable. 

The order is finalized only after submission of a valid prescription and necessary documents. Once the import permit is approved, the licensed supplier arranges shipment of Trodelvy from the USA, Canada, Europe, or Australia, etc.  

With these steps, patients can import sacitizumab-govitecan India safely and legally. We make the medicines available in major Indian cities and source only from genuine international suppliers to ensure safety and authenticity. We ensure 100% transparency in pricing and supply is guaranteed. Prescriptions are dispensed and checked by registered pharmacists before delivery to patients.